Advancing Cancer Epidemiology Through Global Collaboration

Global Cancer Research and Control Seminar Series

February 12, 2026 | 10:00 AM – 11:00 AM

Virtual

Add to Outlook Calendar

Register Now

Continuing Medical Education (CME) credits now available – This activity has been approved for AMA PRA Category 1 Credits™.

Cancer is one of the leading causes of death worldwide, impacting millions across all regions and demographics. Global cancer research is vital to reducing this burden. In this seminar, Dr. Shu will highlight how international collaboration accelerates scientific discovery by leveraging diverse genetic profiles, environmental exposures, and lifestyles. Such cooperation enhances scientific rigor, addresses disparities in cancer incidence and care, and ensures that advances benefit patients everywhere.

Xiao-Ou Shu, M.D., Ph.D., is a chronic disease epidemiologist at Vanderbilt University School of Medicine. She serves as Co-Leader of the Cancer Epidemiology Program and Associate Director for Global Health at the Vanderbilt-Ingram Cancer Center. Dr. Shu is an elected Fellow of the American Association for the Advancement of Science (AAAS), the American College of Epidemiology, and a member of the American Epidemiological Society. Since 1996, she has maintained continuous funding from the National Institutes of Health, leading more than 26 major research projects and five training grants. Her research explores how environmental exposures, lifestyle factors, and genetic susceptibility influence disease, particularly cancer risk and outcomes. She also focuses on biomarker discovery through multidisciplinary approaches. 

Dr. Shu earned her M.D. and M.P.H. from Fudan University Shanghai Medical School and her Ph.D. in epidemiology from Columbia University in New York.